EC 1.3.99.29 [phytoene desaturase (zeta-carotene-forming)] inhibitor

CHEBI:CHEBI_72774

Definition

An EC 1.3.99.* (oxidoreductase acting on donor CH-CH group with other acceptors) inhibitor that interferes with the action of phytoene desaturase (zeta-carotene-forming), EC 1.3.99.29, an enzyme of carotenoid biosynthesis that converts phytoene into zeta-carotene (zeta-carotene) via the symmetrical introduction of two double bonds at the C-11 and C-11' positions of phytoene.

Alternative Names

  • 15-cis-phytoene:acceptor oxidoreductase (zeta-carotene-forming) inhibitor
  • 15-cis-phytoene:acceptor oxidoreductase (zeta-carotene-forming) inhibitors
  • 2-step phytoene desaturase inhibitor
  • 2-step phytoene desaturase inhibitors
  • CrtIa inhibitor
  • CrtIa inhibitors
  • EC 1.3.99.29 [phytoene desaturase (zeta-carotene-forming)] inhibitors
  • EC 1.3.99.29 inhibitor
  • EC 1.3.99.29 inhibitors
  • phytoene dehydrogenase inhibitor
  • phytoene dehydrogenase inhibitors
  • phytoene desaturase (zeta-carotene-forming) (EC 1.3.99.29) inhibitor
  • phytoene desaturase (zeta-carotene-forming) (EC 1.3.99.29) inhibitors
  • phytoene desaturase (zeta-carotene-forming) inhibitor
  • phytoene desaturase (zeta-carotene-forming) inhibitors
  • phytoene desaturase inhibitor
  • phytoene desaturase inhibitors
  • two-step phytoene desaturase inhibitor
  • two-step phytoene desaturase inhibitors

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

core#notation
CHEBI:72774

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

oboInOwl#hasOBONamespace
chebi_ontology
oboInOwl#id
CHEBI:72774
core#notation
CHEBI:72774
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#3_STAR
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
RO_0000087
http://purl.obolibrary.org/obo/CHEBI_4640
owl#someValuesFrom
t224056
owl#annotatedSource
t280256